Document Reviewers: Luis Aguinaga, MD; Timothy SE Albert, MD, FACC; Peter F. Aziz, MD,
FHRS; Alec Block, MD; Peter Brady, MB, ChB, MD; Mina Chung, MD, FACC; Michael …

The writing committee consisted of acknowledged experts in the field of CMR, as well as a
liaison from the ACCF Task Force on Clinical ECDs, the oversight group for this document …

Pacemaker treatment for bradyarrhythmia was first approved for national health insurance
coverage in Japan in 1974, and its use rapidly became widespread thereafter …

Background The presence of a cardiovascular implantable electronic device has long been
a contraindication for the performance of magnetic resonance imaging (MRI). We …

Background Patients who have pacemakers or defibrillators are often denied the opportunity
to undergo magnetic resonance imaging (MRI) because of safety concerns, unless the …

Background: Magnetic resonance imaging (MRI) is avoided in most patients with implanted
cardiac devices because of safety concerns. Objective: To define the safety of a protocol for …

Dramatic increases in both magnetic resonance imaging (MRI) usage and cardiac device‐
based therapy have resulted in an estimated 50–75% probability of a patient being indicated …

Advances in magnetic resonance (MR) imaging over the past 2 decades have led to MR
becoming an increasingly attractive imaging modality. With the growing number of patients …

BACKGROUND: Magnetic resonance imaging (MRI) of pacemaker patients is
contraindicated due to documented potential risks to the patient from hazardous interactions …

Background—Magnetic resonance imaging (MRI) is an important diagnostic modality
currently unavailable for millions of patients because of the presence of implantable cardiac …